In yesterday’s Wall Street session, Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) shares traded at $1.33, down -66.67% from the previous session.
As of this writing, 1 analysts cover Adamis Pharmaceuticals Corporation (NASDAQ:ADMP). The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $105.00 and a low of $105.00, we find $105.00. Given the previous closing price of $3.99, this indicates a potential upside of 2531.58 percent. ADMP stock price is now -39.29% away from the 50-day moving average and -84.97% away from the 200-day moving average. The market capitalization of the company currently stands at $4.27M.
There are 1 analysts who have given it a hold rating, whereas 0 have given it a buy rating. Brokers who have rated the stock have averaged $105.00 as their price target over the next twelve months.
With the price target maintained at $1.50, Maxim Group recently Upgraded its rating from Hold to Buy for Adamis Pharmaceuticals Corporation (NASDAQ: ADMP).
A total of 7.81% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in ADMP stock. A new stake in Adamis Pharmaceuticals Corporation shares was purchased by ARMISTICE CAPITAL, LLC during the first quarter worth $276,000. CITADEL ADVISORS LLC invested $6,000 in shares of ADMP during the first quarter.
During the past 12 months, Adamis Pharmaceuticals Corporation has had a low of $1.31 and a high of $27.80. The fifty day moving average price for ADMP is $2.1474 and a two-hundred day moving average price translates $8.8144 for the stock.
According to the Drug Manufacturers – Specialty & Generic Company, earnings per share came in at -$0.06, missing analysts’ expectations of -$0.03 by -0.03. This compares to -$0.08 EPS in the same period last year. The company reported revenue of $1.45 million for the quarter, compared to $1.16 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 25.8 percent. For the current quarter, analysts expect ADMP to generate $1.51M in revenue.
